Clinical Observation of Paroxysmal Atrial Fibrillation
Chen Yong-zhan
Abstract
Chen Yong-zhan
Abstract
Objective Discuss Treatment and Clinical effect of Paroxysmal atrial fibrillation.Methods Select our hospital from June 2007 to June 2008 80 patients admitted to frequent episodes of atrial fibrillation were enrolled,Randomly divided into two groups and the control group,The control group with conventional therapy,Observation group were based on the use of simvastatin treatment,1 year follow-up,Two groups were compared C-reactive protein(CRP) levels、Recurrence rate and adverse effects.Results The patients in the CRP level was significantly better than the control group improved,P0.05;Two groups of patients had no adverse reaction,The recurrence rate was the observation group 20.0%(8 / 40) was significantly lower than the control group 42.5%(17/40),P 0.05.Conclusion Simvastatin inhibits inflammatory response,Reduce the recurrence of paroxysmal atrial fibrillation,Worthy of clinical.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective Discuss Treatment and Clinical effect of Paroxysmal atrial fibrillation.Methods Select our hospital from June 2007 to June 2008 80 patients admitted to frequent episodes of atrial fibrillation were enrolled,Randomly divided into two groups and the control group,The control group with conventional therapy,Observation group were based on the use of simvastatin treatment,1 year follow-up,Two groups were compared C-reactive protein(CRP) levels、Recurrence rate and adverse effects.Results The patients in the CRP level was significantly better than the control group improved,P0.05;Two groups of patients had no adverse reaction,The recurrence rate was the observation group 20.0%(8 / 40) was significantly lower than the control group 42.5%(17/40),P 0.05.Conclusion Simvastatin inhibits inflammatory response,Reduce the recurrence of paroxysmal atrial fibrillation,Worthy of clinical.
Key concepts: Medicine, Paroxysmal atrial fibrillation, Atrial fibrillation, Simvastatin, Internal medicine, Adverse effect, Cardiology